Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000494186 | SCV000582866 | pathogenic | not provided | 2017-05-22 | criteria provided, single submitter | clinical testing | The c.268dupC pathogenic variant in the CTSD gene has been reported previously as a homozygous change in two siblings with myoclonic epilepsy, respiratory failure, and cathepsin D deficiency (Meyer et al., 2015). Due to use of alternative nomenclature, this variant has been reported as c.268_269insC (Meyer et al., 2015). The c.268dupC variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The duplication causes a frameshift starting with codon Glutamine 90, changes this amino acid to a Proline residue and creates a premature Stop codon at position 50 of the new reading frame, denoted p.Gln90ProfsX50. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. |
Labcorp Genetics |
RCV002527103 | SCV003292943 | pathogenic | Neuronal ceroid lipofuscinosis | 2024-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln90Profs*50) in the CTSD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTSD are known to be pathogenic (PMID: 16670177, 26059544). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with clinical features of neuronal ceroid lipofuscinosis (PMID: 26059544, 29373990). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 430138). For these reasons, this variant has been classified as Pathogenic. |
Juno Genomics, |
RCV004796203 | SCV005416791 | pathogenic | Neuronal ceroid lipofuscinosis 10 | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PM3_Supporting+PP1_Moderate |